Simone J. C. F. M. Moorlag

Simone J. C. F. M. Moorlag

Auto-generated profile, based on publicly available information

Simone J. C. F. M. Moorlag

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell Reports
Verified
Journal Article
Open access
SMSimone J.C.F.M. Moorlag
Simone J.C.F.M. Moorlag
YRYessica Alina Rodriguez-Rosales
Yessica Alina Rodriguez-Rosales
JGJoshua Gillard
Joshua Gillard
SFStephanie Fanucchi
Stephanie Fanucchi
KTKate Theunissen
Kate Theunissen
MNMihai G. Netea
Mihai G. Netea
The tuberculosis vaccine bacillus Calmette-Guérin (BCG) protects against some heterologous infections, probably via induction of non-specific innate immune memory in monocytes and natural killer (NK) cells, a process known as trained immunity. Recent studies have revealed that the induction of trained immunity is associated with a bias toward granulopoiesis in bone marrow hematopoietic progenitor cells, but it is unknown whether BCG vaccination also leads to functional reprogramming of mature neutrophils. Here, we show that BCG vaccination of healthy humans induces long-lasting changes in neutrophil phenotype, characterized by increased expression of activation markers and antimicrobial function. The enhanced function of human neutrophils persists for at least 3 months after vaccination and is associated with genome-wide epigenetic modifications in trimethylation at histone 3 lysine 4. Functional reprogramming of neutrophils by the induction of trained immunity might offer novel therapeutic strategies in clinical conditions that could benefit from modulation of neutrophil effector function.

25 October 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PDPriya A Debisarun
Priya A Debisarun
KGKatharina Gössling
Katharina Gössling
OBOzlem Bulut
Ozlem Bulut
GKGizem Kilic
Gizem Kilic
MZMartijn Zoodsma
Martijn Zoodsma
MNMihai G. Netea
Mihai G. Netea
Non-specific protective effects of certain vaccines have been reported, and long-term boosting of innate immunity, termedtrained immunity, has been proposed as one of the mechanisms mediating these effects. Several epidemiological studies suggested cross-protection between influenza vaccination and COVID-19. In a large academic Dutch hospital, we found that SARS-CoV-2 infection was less common among employees who had received a previous influenza vaccination: relative risk reductions of 37% and 49% were observed following influenza vaccination during the first and second COVID-19 waves, respectively. The quadrivalent inactivated influenza vaccine induced a trained immunity program that boosted innate immune responses against various viral stimuli and fine-tuned the anti-SARS-CoV-2 response, which may result in better protection against COVID-19. Influenza vaccination led to transcriptional reprogramming of monocytes and reduced systemic inflammation. These epidemiological and immunological data argue for potential benefits of influenza vaccination against COVID-19, and future randomized trials are warranted to test this possibility.

16 December 2017 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
SMSimone J.C.F.M. Moorlag
Simone J.C.F.M. Moorlag
RRRutger Jan Röring
Rutger Jan Röring
LJLeo A.B. Joosten
Leo A.B. Joosten
MNMihai G. Netea
Mihai G. Netea

21 February 2022 in Cell Reports
Verified
Journal Article
Open access
EKEva Kaufmann
Eva Kaufmann
NKNargis Khan
Nargis Khan
KTKim A. Tran
Kim A. Tran
AUAntigona Ulndreaj
Antigona Ulndreaj
EPErwan Pernet
Erwan Pernet
MDMaziar Divangahi
Maziar Divangahi
Since the vast majority of species solely rely on innate immunity for host defense, it stands to reason that a critical evolutionary trait like immunological memory evolved in this primitive branch of our immune system. There is ample evidence that vaccines such as bacillus Calmette-Guérin (BCG) induce protective innate immune memory responses (trained immunity) against heterologous pathogens. Here we show that while BCG vaccination significantly reduces morbidity and mortality against influenza A virus (IAV), it fails to provide protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In contrast to IAV, SARS-CoV-2 infection leads to unique pulmonary vasculature damage facilitating viral dissemination to other organs, including the bone marrow (BM), a central site for BCG-mediated trained immunity. Finally, monocytes from BCG-vaccinated individuals mount an efficient cytokine response to IAV infection, while this response is minimal following SARS-CoV-2. Collectively, our data suggest that the protective capacity of BCG vaccination is contingent on viral pathogenesis and tissue tropism.

5 August 2022 in Science Advances
Verified
Journal Article
Open access
SBSamantha Bannister
Samantha Bannister
BKBowon Kim
Bowon Kim
Jorge Dominguez‐AndresJorge Dominguez‐Andres
Jorge Dominguez‐Andres
GKGizem Kilic
Gizem Kilic
BABrendan R. E. Ansell
Brendan R. E. Ansell
BNBoris Novakovic
Boris Novakovic
Trained immunity describes the capacity of innate immune cells to develop heterologous memory in response to certain exogenous exposures. This phenomenon mediates, at least in part, the beneficial off-target effects of the BCG vaccine. Using an in vitro model of trained immunity, we show that BCG exposure induces a persistent change in active histone modifications, DNA methylation, transcription, and adenosine-to-inosine RNA modification in human monocytes. By profiling DNA methylation of circulating monocytes from infants in the MIS BAIR clinical trial, we identify a BCG-associated DNA methylation signature that persisted more than 12 months after neonatal BCG vaccination. Genes associated with this epigenetic signature are involved in viral response pathways, consistent with the reported off-target protection against viral infections in neonates, adults, and the elderly. Our findings indicate that the off-target effects of BCG in infants are accompanied by epigenetic remodeling of circulating monocytes that lasts more than 1 year.

25 November 2021 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
SMSimone J.C.F.M. Moorlag
Simone J.C.F.M. Moorlag
VMVasiliki Matzaraki
Vasiliki Matzaraki
JPJelmer H. van Puffelen
Jelmer H. van Puffelen
CHCharlotte van der Heijden
Charlotte van der Heijden
SKSam Keating
Sam Keating
MNMihai G. Netea
Mihai G. Netea
Innate immune cells are able to build memory characteristics via a process termed “trained immunity.” Host factors that influence the magnitude of the individual trained immunity response remain largely unknown. Using an integrative genomics approach, our study aimed to prioritize and understand the role of specific genes in trained immunity responses. In vitro‐induced trained immunity responses were assessed in two independent population‐based cohorts of healthy individuals, the 300 Bacillus Calmette‐Guérin (300BCG; n = 267) and 200 Functional Genomics (200FG; n = 110) cohorts from the Human Functional Genomics Project. Genetic loci that influence cytokine responses upon trained immunity were identified by conducting a meta‐analysis of QTLs identified in the 300BCG and 200FG cohorts. From the identified QTL loci, we functionally validated the role of PI3K‐Akt signaling pathway and two genes that belong to the family of Siglec receptors (Siglec‐5 and Siglec‐14). Furthermore, we identified the H3K9 histone demethylases of the KDM4 family as major regulators of trained immunity responses. These data pinpoint an important role of metabolic and epigenetic processes in the regulation of trained immunity responses, and these findings may open new avenues for vaccine design and therapeutic interventions.